News & Events

News

TSO3 to hold Q3 2011 Financial Results Conference Call

Quebec City, October 25, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) announced today that it will report Financial Results for the third quarter of 2011, for the period ending September 30 2011, on Wednesday, November 2, 2011. TSO3 will host a Conference Call and a Webcast at 10:30 A.M. (ET) the same day to discuss financial results and to update on recent activities.

Read more

TSO3 Provides an Update on Commercial Launch and Regulatory Activities – Customers Report High Satisfaction with New Sterilizer

Quebec City, Canada, September 30, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in low temperature sterile reprocessing solutions for medical devices in healthcare settings, today outlined commercial progress in cleared markets, as well as gave details on the program to upgrade customers of the first generation sterilizer (TSO3 125L Ozone Sterilizer) to that of the new generation sterilizer commercialized by 3M, under the brand 3M™ Optreoz™ 125-Z Sterilizer. The Company also acknowledged being actively engaged in the US regulatory process for clearance of the product in the United States.

Read more

TSO3 CEO Presenting at Canaccord Growth Conference in Boston

Quebec City, August 11, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in sterilization technology for medical devices in healthcare settings, announced today that Mr. R.M. (Ric) Rumble, CEO of TSO3, will be giving a corporate presentation at 11:00 a.m (ET) today, at the Canaccord Genuity Annual Growth Conference.

Read more

TSO3 Announces Financial Results for Q2 2011

Quebec City, August 9, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in sterilization technology for medical devices in healthcare settings, posted its highest quarterly revenues in its second quarter of 2011. For the period ending June 30, 2011, the Company posted revenues of $703,000 from the sales of 3M™ Optreoz™ 125-Z Sterilizers, accessories, consumables and service contracts, as well as license revenues. This amount also includes sales of supplies and service contracts on first generation sterilizers (125L). These revenues compare to Q2 2010 revenues of $545,604, for the sale of 3M™ Optreoz™ Sterilizers, accessories, supplies and service contracts to 3M™ for training purposes. For the six-month period ended June 30, 2011, revenues amounted to $892,554 compared to $733,878 for the same period in 2010. The difference is explained by higher sales of private labelled 3M™ Optreoz Sterilizers and Accessories as a result of initial 3M™ commercial activity.

Read more

TSO3 Files for Commercial Clearance in the United States

Quebec City, June 30, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has resubmitted documentation to the United States (U.S.) regulatory authorities for the company’s STERIZONE® 125L+ Sterilizer (3M™ Optreoz™ 125-Z). Such a filing is in support of obtaining clearance for the new generation sterilizer to be sold within the United States.

Read more

Events

Sorry, no posts matched your criteria.